title: Cardiovascular effects induced by rolipram, a selective cAMP phosphodiesterase inhibitor: interaction with adrenergic and calcium affecting drugs.
authors.affiliation: Institute of Pharmacology, Faculty of Medicine and Surgery, University of Palermo, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Novara
authors.forename: A
authors.initials: A
authors.lastname: Flugy
authors.forename: A
authors.initials: A
authors.lastname: Antona
authors.forename: S
authors.initials: S
authors.lastname: Latteri
authors.forename: M
authors.initials: M
authors.lastname: Palazzoadriano
authors.forename: G
authors.initials: G
authors.lastname: Cannizzaro
mesh_terms: D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000818:Animals; D002120:Calcium Channel Agonists / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000494:pharmacology*; D011817:Rabbits; D020889:Rolipram; D013566:Sympathomimetics / Q000494:pharmacology*
chemical_list: D002120:Calcium Channel Agonists; D002121:Calcium Channel Blockers; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D013566:Sympathomimetics; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D020889:Rolipram